Navigation Links
Excelera Corp. Announces Commitments by National Leaders
Date:12/9/2013

Minneapolis, MN (PRWEB) December 09, 2013

Excelera Corp., a national specialty pharmacy network, announced that three leading health systems—Catholic Health Initiatives (CHI), Fairview Health Services, and Intermountain Healthcare—have committed resources, expertise and investment capital to support its model of integrated care for patients who require specialty drugs.

Excelera Corp., a network of specialty pharmacies based at health systems and academic medical centers, was formed in 2012 to enable member organizations to gain access to limited-distribution drugs and provide continuity of care for patients with complex conditions who require specialty drugs.

“This partnership is designed to help us develop a national specialty drug network that is focused on better outcomes for our patients who so desperately need these medications,” said Kevin Lofton, president and chief executive officer of Englewood, Colo.-based CHI, one of the nation’s largest health systems. “The Excelera network gives our doctors access to a comprehensive, integrated network, including limited-distribution drugs, which enables them to manage the full spectrum of patient care.”

Specialty pharmaceuticals are expensive drugs that may require special handing and administration and are often used to treat the most ill and clinically complex patients.

“Excelera supports exceptional treatment for chronic and acute illnesses by improving access to specialty pharmacy services,” said Dan Fromm, senior vice president and chief financial officer at Fairview Health Services. “By establishing best practice care protocols and by managing specialty pharmaceuticals at the point of care, we believe we can improve patient adherence, more effectively manage the continuum of care and positively impact clinical outcomes and the experience of our patients and caregivers.”

Most health plans now require patients to obtain specialty drugs from an outside specialty pharmacy that has no direct relationship with the patient. The health system does not have control as to when the patient initiates therapy and is not able to manage or monitor it. As a result, health systems and payers may incur higher medical costs, lower patient satisfaction, and suboptimal health outcomes as care plans are not fulfilled as intended.

The Excelera network will negotiate on behalf of its member organizations to remove barriers to specialty drug access and monitoring. Patients and providers of health systems in the Excelera network will benefit by working with a specialty pharmacy that is a member of their care team, can easily access specialty pharmaceuticals, and knows the patient’s care plan.

“Intermountain Healthcare firmly believes that this specialty pharmacy will be a great benefit to its patients,” said Nannette Berensen, Intermountain’s assistant vice president of pharmacy services. “We are pleased to be joining together with other leading institutions to provide this service.”

In addition to the three investor members named here, the Excelera organization also includes Henry Ford Health System, Marshfield Clinic, Avera Health, and Regional Health. The Excelera board of directors consists of Bob Beacher, president, pharmacy and shared clinical services, Fairview Health Services; Nick Barto, senior vice president of capital finance, Catholic Health Initiatives; and Albert R. Zimmerli, executive vice president and chief financial officer, Intermountain Healthcare. For more information about the Excelera organization, visit http://www.excelerarx.com.

About Catholic Health Initiatives
Catholic Health Initiatives is a national nonprofit health system with headquarters in Englewood, Colo. The faith-based organization operates in 18 states and comprises 87 hospitals, including 24 critical-access facilities and four academic medical teaching centers; two community health-services organizations; two accredited nursing colleges; home health agencies; and long-term care, assisted- and residential-living facilities; CHI is the nation’s third-largest nonprofit health system, with annual operating revenues of $12.6 billion and approximately 90,500 employees. In fiscal year 2013, CHI provided $762 million in charity care and community benefit, including services for the poor, free clinics, education and research.

About Fairview Health Services
Fairview Health Services, headquartered in Minneapolis, is a non-profit, academic health system providing exceptional health care across the entire continuum. In partnership with the University of Minnesota, our 22,000 employees and more than 3,000 credentialed physicians embrace innovation and new thinking to deliver greater value—higher quality, better experience and lower cost.

About Intermountain Healthcare
Intermountain Healthcare is a Utah-based nonprofit system of 22 hospitals, 185 clinics, a Medical Group with more than 1,000 employed physicians, a health plans division called SelectHealth, and other health services. Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit http://www.intermountainhealthcare.org.

Contacts:
Jennifer Amundson, Fairview Health Services, 612-672-4165
Michael Romano, Catholic Health Initiatives, 720-383-2720
Daron Cowley, Intermountain Healthcare, 801-442-2834

Read the full story at http://www.prweb.com/releases/2013/12/prweb11401515.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
2. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
3. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
4. Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.
5. BioSpecifics Technologies Corp. Reports Second Quarter 2012 Financial Results
6. BioSpecifics Technologies Corp. To Present at UBS Global Life Sciences Conference
7. BioSpecifics Technologies Corp. Reports Third Quarter 2012 Financial Results
8. BioSpecifics Technologies Corp. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Free Research Report on Dyax Corp., Ebix, Inc., 8x8, Inc., EnerSys and Express Scripts Holding Co.
10. Tonicology LLC Partners with Taiwan's CGB, Corp. to Offer Pure Extracts of Rare Herbal Supplements
11. Plastics Color Corp. Announces Custom-Blended Antimicrobials for Polymers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... and GERMANTOWN, Maryland , ... Frankfurt Prime Standard: QIA) today announced the introduction of ... gene expression profiling, expanding QIAGEN,s portfolio of Sample to ... researchers to select from over 20,000 human genes and ... between genes, cellular phenotypes and disease processes. --> ...
(Date:2/11/2016)... , Feb. 11, 2016  Spectra BioPharma Selling ... (CSO) that provides biopharma companies the experience, expertise, ... and deploy outsourced sales teams. Created in concert ... addresses both the strategic and tactical needs of ... sales solutions through both personal and non-personal promotion. ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... cutting-edge information focused on the development and manufacture of biopharmaceuticals and therapeutics, ... sponsor of the 2016 BioProcess International Awards – Recognizing Excellence in the ...
(Date:2/11/2016)... , February 11, 2016 ... ("PositiveID" or "Company") (OTCQB: PSID), a life sciences ... that its Thermomedics subsidiary, which markets the Caregiver® ... growth plan in January 2016, including entering into ... sequential monthly sales growth, and establishing several near-term ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016  Based on ... Frost & Sullivan recognizes US-based Intelligent Retinal Imaging ... & Sullivan Award for New Product Innovation. IRIS, ... North America , is poised ... rapidly growing diabetic retinopathy market. The IRIS technology ...
(Date:1/28/2016)... Synaptics (NASDAQ: SYNA ), a leading developer of human interface ... 31, 2015. --> --> ... percent compared to the comparable quarter last year to $470.5 million. ... million, or $0.93 per diluted share. --> ... of fiscal 2016 grew 9 percent over the prior year period ...
(Date:1/22/2016)... , January 22, 2016 /PRNewswire/ ... announced the addition of the  "Global ... their offering. --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) ...
Breaking Biology News(10 mins):